SERBP1 Is a Component of the Liver Receptor Homologue-1 Transcriptional Complex

被引:7
|
作者
Mari, Yelenis [1 ]
West, Graham M. [2 ]
Scharager-Tapia, Catherina [2 ]
Pascal, Bruce D. [3 ]
Garcia-Ordonez, Ruben D. [1 ]
Griffin, Patrick R. [1 ]
机构
[1] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA
[2] Scripps Res Inst, Mass Spectrometry & Prote Core, Jupiter, FL 33458 USA
[3] Scripps Res Inst, Informat Core, Jupiter, FL 33458 USA
基金
美国国家卫生研究院;
关键词
liver receptor homologue-1 (LRH1; NR5A2); nuclear receptor; interleukin enhancer binding factor-3 (ILF3); SERPINE1 mRNA binding protein-1 (SERBP1); protein arginine methyltransferase 1 (PRMT1); peroxisome proliferator-activated receptor gamma co-activator-1 alpha (PGC1 alpha); RNA-BINDING-PROTEIN; IMMORTALIZED GRANULOSA-CELLS; STEROIDOGENIC FACTOR-I; MEMBRANE COMPONENT-1; NUCLEAR RECEPTORS; MESSENGER-RNA; LRH-1; EXPRESSION; CANCER; IDENTIFICATION;
D O I
10.1021/acs.jproteome.5b00379
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Liver receptor homologue-1 (LRH1) is an orphan nuclear receptor that has been shown to play a role in the transcriptional regulation of pathways involved in cancer. Elucidating the components of the LRH1 transcriptional complex to better understand endogenous regulation of the receptor as well as its role in cancer remains a high priority. A sub-cellular enrichment strategy coupled with proteomic approaches was employed to identify putative LRH1 co-regulators. Nuclear fractionation protocol was essential for detection of LRH1 peptides by mass spectrometry (MS), with most peptides being observed in the insoluble fraction (receptor bound to DNA). SERBP1 and ILF3 were identified as LRH1 interacting partners by both Western blot and MS/MS analysis. Receptor knockdown by siRNA showed an increase in SERBP1 expression, while ILF3 expression was unchanged. In contrast, receptor overexpression decreased only SERBP1 mRNA levels. Consistent with these data, in a promoter:reporter assay, binding of LRH1 to the promoter region of SERBP1 resulted in a decrease in the expression level of the reporter gene, subsequently inhibiting transcription. Given the receptor's role in cancer progression, the study here elucidates additional transcriptional machinery involved in LRH1 signaling and potentially provides new targets for therapeutics development.
引用
收藏
页码:4571 / 4580
页数:10
相关论文
共 50 条
  • [41] lncRNA TMPO-AS1 Exerts Oncogenic Roles in HCC Through Regulating miR-320a/SERBP1 Axis
    Wang, Zhenchang
    Huang, DanDan
    Huang, Jingjing
    Nie, Kunmei
    Li, Xiaofan
    Yang, Xiaojin
    ONCOTARGETS AND THERAPY, 2020, 13 : 6539 - 6551
  • [42] MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1
    Wang, Ting
    Xu, Ling
    Jia, Rongrong
    Wei, Jue
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2017, 49 (05) : 383 - 391
  • [43] Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis
    Nuran Bektas Serce
    Andreas Boesl
    Irina Klaman
    Sonja von Serényi
    Erik Noetzel
    Michael F Press
    Arno Dimmler
    Arndt Hartmann
    Jalid Sehouli
    Ruth Knuechel
    Matthias W Beckmann
    Peter A Fasching
    Edgar Dahl
    BMC Cancer, 12
  • [44] miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer
    Cao, Shujun
    Li, Na
    Liao, Xihong
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [45] Non-Classical Progesterone Receptor (PGRMC1) and SERPINE1 mRNA Binding Protein (SERBP1) Interaction Influences the Human Decidualization Process.
    Salsano, Stefania
    Quinonero, Alicia
    Perez, Silvia
    Simon, Carlos
    Dominguez, Francisco
    REPRODUCTIVE SCIENCES, 2017, 24 : 69A - 69A
  • [46] Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer:: Association with tumor progression
    Koensgen, Dominique
    Mustea, Alexander
    Klaman, Irina
    Sun, Pengming
    Zafrakas, Menelaos
    Lichtenegger, Wemer
    Denkert, Carsten
    Dahl, Edgar
    Sehouli, Jalid
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 266 - 273
  • [47] Interleukin enhancer-binding factor 3 functions as a liver receptor homologue-1 co-activator in synergy with the nuclear receptor co-activators PRMT1 and PGC-1α
    Ohno, Masae
    Komakine, Jun
    Suzuki, Eiko
    Nishizuka, Makoto
    Osada, Shigehiro
    Imagawa, Masayoshi
    BIOCHEMICAL JOURNAL, 2011, 437 : 531 - 540
  • [48] miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer
    Shujun Cao
    Na Li
    Xihong Liao
    Journal of Ovarian Research, 14
  • [49] The RNA-binding protein SERBP1 regulates mTOR expression by interacting with G-quadruplexes
    Libich, David
    Baudin, Antoine
    Alers, Victoria
    Xu, Xiaoping
    Clark, Kyra
    Penalva, Luiz
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03) : S722 - S722
  • [50] Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis
    Serce, Nuran Bektas
    Boesl, Andreas
    Klaman, Irina
    von Serenyi, Sonja
    Noetzel, Erik
    Press, Michael F.
    Dimmler, Arno
    Hartmann, Arndt
    Sehouli, Jalid
    Knuechel, Ruth
    Beckmann, Matthias W.
    Fasching, Peter A.
    Dahl, Edgar
    BMC CANCER, 2012, 12